TAXIS Pharmaceutical Revenue and Competitors
Estimated Revenue & Valuation
- TAXIS Pharmaceutical's estimated annual revenue is currently $3.8M per year.
- TAXIS Pharmaceutical's estimated revenue per employee is $104,000
Employee Data
- TAXIS Pharmaceutical has 37 Employees.
- TAXIS Pharmaceutical grew their employee count by 3% last year.
TAXIS Pharmaceutical's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Director Microbiology | Reveal Email/Phone |
3 | Research Scientist | Reveal Email/Phone |
TAXIS Pharmaceutical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 26 | -4% | $15.7M | N/A |
#2 | $1.4M | 21 | -50% | $21.2M | N/A |
#3 | $41.9M | 293 | 8% | $6M | N/A |
#4 | $6M | 53 | -22% | $216.8M | N/A |
#5 | $0M | 2 | 0% | $33.3M | N/A |
#6 | $26M | 182 | 0% | N/A | N/A |
#7 | $30.9M | 221 | -26% | $64.6M | N/A |
#8 | $28.6M | 205 | -22% | $46.8M | N/A |
#9 | $249.1M | 1340 | 15% | $75M | N/A |
#10 | $12.4M | 95 | 3% | N/A | N/A |
What Is TAXIS Pharmaceutical?
Founded in March, 2009, TAXIS Pharmaceuticals is focused on the discovery and development of pharmaceuticals targeting multidrug-resistant bacterial pathogens that constitute a worldwide therapeutic category estimated to exceed $30B in annual sales revenues. The initial series of proprietary lead candidates, referred to as the azachryseniums (AZCs), display in vitro activity that is superior to current standards of care for a broad range of Gram-positive bacterial pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).
keywords:N/AN/A
Total Funding
37
Number of Employees
$3.8M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
TAXIS Pharmaceutical News
Stocks To Watch Today: Gland Pharma, JSPL, JSW Energy, TVS Motor, L&T Technology ... to provide engineering services for the Jaunt Journey eVTOL air taxi.
Nymox Pharmaceutical Evolva Destiny Pharma Viral Genetics Sequoia Sciences Taxis Pharmaceuticals. Continue
It is a testament to his dedication in delivering service excellence, having grown a pharmaceutical client account from its beginning into a...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.5M | 37 | -16% | N/A |
#2 | $4.7M | 37 | -14% | N/A |
#3 | $4.9M | 37 | 0% | N/A |
#4 | $4.3M | 37 | 3% | N/A |
#5 | $4.4M | 37 | -7% | N/A |